Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment

Por um escritor misterioso

Descrição

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Multidrug resistance in cancer: role of ATP–dependent transporters
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Increased drug efflux mediated by overexpression of P-glycoprotein
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Targeting cancer stem cells for reversing therapy resistance
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Exosomes and breast cancer drug resistance
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Presumed mechanisms of P-glycoprotein (P-gp)-mediated drug
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Novel strategies to prevent the development of multidrug
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Biomedicines, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Simplified Derivatives of Tetrandrine as Potent and Specific P-gp
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Life, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Approaches to minimize the effects of P‐glycoprotein in drug
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Phytochemicals reverse P-glycoprotein mediated multidrug
de por adulto (o preço varia de acordo com o tamanho do grupo)